Schardt, John S <br/><br/>
HER3-Targeted Affibodies with Optimized Formats Reduce Ovarian Cancer Progression in a Mouse Xenograft Model.  [electronic resource] 

 -  The AAPS journal  04 2019 
 - 48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-7416 
<br/><br/><label>Standard No.: </label>10.1208/s12248-019-0318-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carboplatin--pharmacology<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Female<br/>Half-Life<br/>Humans<br/>Mice<br/>Ovarian Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptor, ErbB-3--antagonists & inhibitors<br/>Recombinant Fusion Proteins--pharmacology<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays